Advertisement

Der Hautarzt

, Volume 53, Issue 3, pp 202–206 | Cite as

Vesikel, Lichtempfindlichkeit, orale Ulzerationen und Arthralgien bei einer 40-Jührigen

  • A. Kolb-Müurer
  • S. Herzog
  • C. Sitaru
  • C. Kneitz
  • D. Zillikens
  • M. GoebelerEmail author
Wie lautet Ihre Diagnose?

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

Literatur

  1. 1.
    Gammon WR, Woodley DT, Dole KC, Briggaman RA (1985) Evidence that antibasement membrane zone antibodies in bullous eruption of systemic lupus erythematosus recognize epidermolysis acquisita autoantigen. J Invest Dermatol 84:472-476PubMedCrossRefGoogle Scholar
  2. 2.
    Gammon WR, Murrell DF, Jenison MW et al. (1993) Autoantibodies to type VII collagen recognize epitopes in a fibronectin-like region of the noncollagenous (NC1) domain. J Invest Dermatol 100:618–622PubMedCrossRefGoogle Scholar
  3. 3.
    Gammon WR, Briggaman RA (1993) Bullous SLE: a phenotypically distinctive but immunologically heterogeneous bullous disorder. J Invest Dermatol 100:28S–34SPubMedCrossRefGoogle Scholar
  4. 4.
    Hall RP, Lawley TJ, Smith HR, Katz SI (1982) Bullous eruption of systemic lupus erythematosus: dramatic response to dapsone therapy. Ann Intern Med 97:165–170PubMedCrossRefGoogle Scholar
  5. 5.
    Jainta S, Schmidt E, Bröcker EB, Zillikens D (2001) Diagnostik und Therapie bullöser Autoimmunerkrankungen der Haut. Dtsch Ärztebl 98:A1320–1325Google Scholar
  6. 6.
    Kuhn A, Schuppe HC, Ruzicka T, Lehmann P (2000) DeSeltene kutane Manifestationsformen des Lupus erythematodes. Eine klinische Übersicht. Hautarzt 51:818–825PubMedCrossRefGoogle Scholar
  7. 7.
    Lapiere JC, Woodley DT, Parente MG, Iwasaki T, Wynn KC, Christiano AM, Uitto J (1993) Epitope mapping of type VII collagen. Identification of discrete peptide sequences recognized by sera from patients with acquired epidermolysis bullosa. J Clin Invest 92:1831–1839PubMedCentralPubMedCrossRefGoogle Scholar
  8. 8.
    Pedro SD, Dahl MW (1973) Direct immunofluorescence of bullous systemic lupus erythematosus. Arch Dermatol 107:118–120PubMedCrossRefGoogle Scholar
  9. 9.
    Rose C, Dieterich W, Bröcker EB, Schuppan D, Zillikens D (1999) Circulating autoantibodies to tissue transglutaminase differentiate patients with dermatitis herpetiformis from those with linear IgA disease. J Am Acad Dermatol 41:957–961PubMedCrossRefGoogle Scholar
  10. 10.
    Sulkes A, Naparstek Y (1991) The infrequent association of systemic lupus erythematosus and solid tumors. Cancer 68:1389–1393PubMedCrossRefGoogle Scholar
  11. 11.
    Sultan SM, Ioannou Y, Isenberg DA (2000) Is there an association of malignancy with systemic lupus erythematosus? An analysis of 276 patients under long-term review. Rheumatol 39:1147–1152CrossRefGoogle Scholar
  12. 12.
    Tan EM, Cohen AS, Fries JF et al. (1982) The 1982 revised criteria for the classification of systemic lupus erythematosus. Arthritis Rheum 25:1271–1277PubMedCrossRefGoogle Scholar

Copyright information

© Springer-Verlag Berlin Heidelberg 2002

Authors and Affiliations

  • A. Kolb-Müurer
    • 1
  • S. Herzog
    • 1
  • C. Sitaru
    • 1
  • C. Kneitz
    • 2
  • D. Zillikens
    • 1
  • M. Goebeler
    • 1
    Email author
  1. 1.Klinik und Poliklinik für Haut- und Geschlechtskrankheiten der Universitüt WürzburgWürzburgGermany
  2. 2.Medizinische Poliklinik der Universitüt WürzburgWürzburgGermany

Personalised recommendations